Cheung, Alexander T. M.
Palapattu, Elina L.
Pompa, Isabella R. http://orcid.org/0000-0003-1376-1653
Aldrighetti, Christopher M.
Niemierko, Andrzej
Willers, Henning
Huang, Franklin
Vapiwala, Neha
Van Allen, Eliezer
Kamran, Sophia C. http://orcid.org/0000-0001-9283-6515
Article History
Received: 4 October 2022
Accepted: 11 January 2023
First Online: 19 January 2023
Competing interests
: S.C.K. reported having a spouse who is employed by Sanofi Genzyme and receipt of grants from the Prostate Cancer Foundation outside the submitted work. E.V.A. reported advisory and consulting work for Tango Therapeutics, Genome Medical, Invitae, Enara Bio, Janssen, Manifold Bio, and Monte Rosa; he reported research support from Novartis, BMS; he reported equity in Tango Therapeutics, Genome Medical, Syapse, Enara Bio, Manifold Bio, Microsoft, and Monte Rosa; he received travel reimbursement from Roche/Genentech; and he filed institutional patents on chromatin mutations and immunotherapy response and methods for clinical interpretation outside the submitted work. F.H. reported equity in GlaxoSmithKline. No other disclosures were reported.